Medline Inc. Class A common stock vs. Neuropace, Inc. Common Stock
MDLN
Medline Inc. Class A common stock
$39.47 -1.28%
VS NPCENeuropace, Inc. Common Stock
$7.56 -37.10%
Medline Inc. Class A common stock and Neuropace, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| MDLN | NPCE | |
|---|---|---|
| Market Cap | $35.13 billion | $412.58 million |
MDLN leads on 1 of 1 size & scale factors.
Risk & Sentiment
| MDLN | NPCE | |
|---|---|---|
| Short Interest | 1.47% | 0.24% |
NPCE leads on 1 of 1 risk & sentiment factors.
Dig deeper: MDLN overview, MDLN financials, NPCE overview, NPCE financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.